Contraindications with Aldomet
Aldomet (methyldopa; Aspen) is now contraindicated with a catecholamine-secreting tumour, such as pheochromocytoma or paraganglioma, and with porphyria. Additionally, the summary of product characteristics now states that the use of the drug in women who are pregnant or may become pregnant, or in breast-feeding mothers, requires that the anticipated benefits are weighed against potential risks.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200179
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com